Increased CD5+CD19+ B lymphocytes at the onset of type 1 diabetes in children

Acta Diabetologica

Volumn 34, Issue 4, 1997, Pages 271-274

  De Filippo, G ^a   Pozzi, N ^a   Cosentini, E ^a   Cavalcanti, M ^a   Carel, J C ^b   Tamasi, S ^a   Franzese, A ^a   Pignata, C ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b INSERM   (France)

Author keywords

CD5; CD5+ B lymphocytes; Pediatric insulin dependent diabetes mellitus

Indexed keywords

AUTOANTIBODY; CD19 ANTIGEN; CD5 ANTIGEN; DIFFERENTIATION ANTIGEN; INSULIN; LYMPHOCYTE SURFACE MARKER; PANCREAS ISLET CELL ANTIBODY;

ANTIBODY DETECTION; ARTICLE; B LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LYMPHOCYTE COUNT; MALE; PATHOGENESIS; PRIORITY JOURNAL;

AGE OF ONSET; ANTIGENS, CD19; ANTIGENS, CD5; B-LYMPHOCYTE SUBSETS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOPHENOTYPING; ISLETS OF LANGERHANS; MALE; REFERENCE VALUES;

EID: 0031450648     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920050087     Document Type: Article

References (21)

1. Castano L, Eisenbarth GS, Type 1 diabetes: a chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 8:647-679, 1990
2. Atkinson MA, Maclaren NK, The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428-1436, 1994
3. Harrison LC, Chu SX, DeAizpurua HJ, Graham M, Honeyman MC, Colman PG, Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes. J Clin Invest 1992:1161-1165, 1992
4. Matsumoto M, Yagi H, Kunimoto K, Kawaguchi J, Makino S, Harada M, Transfer of autoimmune diabetes from diabetic nod mice to athymic nod mice: the role of T cell subsets in the pathogenesis. Cell Immunol 148:189-197, 1993
5. Raveche ES, Possible immunoregulatory role for CD5+ B cells. Clin Immunol Immunopathol 56:135-150, 1990
6. Hayakawa K, Hardy R, Parks DR, Herzenberg LA, Steinberg AD, Herzenberg LA, Lyl B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci USA 81:2494-2498, 1984
7. Yancopoulos G, Desiderio S, Paskind M, Kearny D, Baltimore D, Alt F, Preferential utilization of the most JH proximal to VH gene segments in pre-B cells. Nature 311:727-733, 1984
8. Antin JH, Emerson SG, Martin P, Gadol N, Ault KA, Leul+ (CD5) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. J Immunol 136:505-510, 1986
9. Smerdon RA, Peakman M, Hussain MJ, Sue Wong F, Watkins PJ, Leslie RDG, Vergani D, CD5+ B-cells at the onset of type I diabetes and in the prediabetic period. Diabetes Care 17:657-664, 1994
10. Boitard C, Bonifacio E, Bottazzo GF, Gleichmann H, Molenaar J, Report of the 3rd international workshop on the standardization of cytoplasmic islet cell antibodies. Diabetologia 31:451-452, 1988
11. Nakamura M, Eng MT, Recent advances in laboratory tests and significance of autoantibodies to nuclear antigens in systemic rheumatic diseases. Clin Lab Med 6:41-53, 1986
12. +) in rheumatoid arthritis and primary Sjogrens syndrome. Clin Exp Immunol 77:175-178, 1989
13. Smith HR, Olson RR, CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 17:833-835, 1990
14. Mix C, Olsson J, Correale J, Baig S, Kostulas V, Olsson O, Link H, B-cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol 79:21-27, 1990
15. Schatz DA, Lang F, Cantor AB, Riley WJ, Maclaren NK, Sleasman JW, Barrett DJ, CD5+ B lymphocytes in high-risk islet cell antibody positive and newly diagnosed IDDM subjects. Diabetes 40:1314-1318, 1991
16. Becker H, Weber C, Storch S, Federlin K, Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity. Clin Immunol Immunopathol 56:219-225, 1990
17. Nicoletti F, Meroni PL, Barcellini W, Steinsvag PO, Di Mauro M, Lunetta M, Pagano M, Consoli U, Zanussi C, Enhanced percentage of CD5+ B lymphocytes in newly diagnosed IDDM patients. Immunol Lett 23:211-215, 1990
18. Holmberg D, Wennerstrom G, Andrade L, Coutinho A, The high idiotypic connectivity of natural newborn antibodies is not found in adult mitogen reactive B cell repertoires. Eur J Immunol 16:82-87, 1986
19. Casali P, Notkins AL, CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 10:364-368, 1989
20. Kasaian MT, Ikemnatsu H, Casali P, Identification and analysis of a novel CD5-B lymphocyte subset producing natural antibodies. J Immunol 148:2690-2695, 1992
21. Munoz A, Gallart T, Usac EF, Fernandez-Alvarez J, Vinas O, Somoza N, Barcelo J, Gomis R, Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM. Diabetologia 38:62-72, 1995